TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/24/25 19:41 | 9/22/25 | OKUR | Onkure Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Leverone Jason A. | CO | O | CFO | S | -1 | 2.62 | 0 | 0 | -2 | 13 | D | ||||||||||||||
6/25/25 18:49 | 6/23/25 | OKUR | Onkure Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Leverone Jason A. | CO | O | CFO | S | -1 | 2.38 | 0 | 0 | -2 | 13 | D | ||||||||||||||
4/8/25 17:30 | 4/4/25 | OKUR | Onkure Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Leverone Jason A. | CO | O | CFO | S.m | -9 | 2.94 | 0 | -3 | -19 | 13 | D | ||||||||||||||
3/17/20 16:22 | 3/13/20 | MGEN | Miragen Therapeutics, Inc. | DE | Health | Health | Medical Laboratories | Leverone Jason A. | CO | O | CFO,Trea | M.d | 6 | 0.5700 | 0 | 11 | 30 | 49 | D | ||||||||||||||
8/23/19 18:16 | 8/23/19 | MGEN | Miragen Therapeutics, Inc. | DE | Health | Health | Medical Laboratories | Leverone Jason A. | CO | O | CFO,Trea | M.d | 2 | 0.5700 | 0 | 3 | 9 | 36 | D | ||||||||||||||
8/9/18 16:18 | 8/7/18 | MGEN | Miragen Therapeutics, Inc. | DE | Health | Health | Medical Laboratories | Leverone Jason A. | CO | O | CFO,Trea | M.d | 17 | 0.5700 | 0 | 30 | 999% | 31 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |